UNIQO 160

UNIQO 160 | AI-powered automation revolutionises IFA testing

The UNIQO 160, an advanced automation system for indirect immunofluorescence assays (IFA), now incorporates AI-based evaluation of results. This innovation enables complete walkaway automation from primary sample to result proposal, significantly enhancing efficiency and standardisation in IFA analysis.

Gentronix kings award

Gentronix receives King’s Award for Enterprise following significant international growth

UK-based toxicology specialist Contract Research Organisation (CRO) Gentronix has been awarded the prestigious King’s Award for Enterprise for 2024 in recognition of its remarkable international trade performance. The Alderley Park-based firm has demonstrated exceptional growth in overseas earnings, with a 239% increase over the past three years.

nuclera

Nuclera secures £1.14M in Innovate UK grants for eProtein Discovery platform

UK-based biotechnology firm Nuclera has been awarded two Innovate UK grants totalling £1.14 million to further develop its eProtein Discovery system. The funding comprises a £790,000 flexible, agile, scalable, and sustainable technologies (FASST) grant and a £350,000 Engineering Biology grant.

celonic

Swiss CDMO expands biologics development capabilities

The Celonic Group, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in quality biologics, has inaugurated its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This expansion aims to support pharmaceutical companies in developing and optimising processes using advanced bioprocessing technologies.

SGS

SGS expands biopharmaceutical stability testing services in Switzerland

SGS, a leading provider of biopharmaceutical testing services, has announced the expansion of its laboratory in Birsfelden, Switzerland, to include stability studies. This addition to the facility’s service portfolio aims to meet the growing demand for comprehensive and reliable stability testing in the bio­pharmaceutical industry.

Icosagen

Strategic partnership to advance monoclonal antibody discovery

Icosagen, a contract research, development, and manufacturing organisation (CRDMO) specialising in innovative antibody research and production, has announced a strategic partnership with Lead Discovery Center GmbH (LDC), a translational drug discovery organisation. The collaboration aims to discover monoclonal antibody portfolios targeting therapeutically relevant proteins, including a pivotal G-protein coupled receptor (GPCR), which are often challenging […]

Vetter

Vetter expands global manufacturing capacity for injectable therapeutics

Leading contract development and manufacturing organisation (CDMO) Vetter has announced significant expansion plans in both the United States and Germany, aiming to meet the growing demand for outsourced development and manufacturing of injectable medications.

Scherm­afbeelding 2024 07 01 om 16.52.50

ELRIG UK announces keynote speakers for Drug Discovery 2024

The European Laboratory Research & Innovation Group (ELRIG) UK has revealed the keynote speakers for its flagship conference, Drug Discovery 2024. The event, scheduled for 2-3 October at ExCeL London, will feature presentations from two distinguished scientists in the field of pharmaceutical research and development.

AdobeStock 706467109

The science of safety | Promoting ergonomic practices in the lab

By LaNiesha Littleton Repetitive manual tasks are common in many laboratories, making the risk of repetitive strain injuries and musculoskeletal disorders a significant concern for businesses and employees alike. This article highlights the importance of injury prevention through expert support and ergonomic solutions, and explores how the workplace health and safety landscape is now being […]

AdobeStock 585907876

Insight into DNA methylation analysis

The association of epigenetic changes with disease pathogenesis is the subject of much study. CLI caught up with Dr Kathleen Barnes (Oxford Nanopore Technologies) to find out more about how DNA methylation is linked to disease as well as developments in methods of DNA methylation analysis for improving disease diagnosis, prognostic stratification and therapy.